West Pharmaceutical Services, Inc.
NYSEWST put-call ratio plunges to 0.86, hitting a 4-standard-deviation low versus the 20-day mean of 1.22—signaling extreme bullish sentiment and the weakest protective hedging in months.
Snapshot as of 29 Jun 2026
Options positioning for WST has flipped sharply in less than a week. Short sellers are also retreating. The signals point the same direction. On May 15, the put/call ratio hit 2.25 — the highest in two months. Five…
West Pharmaceutical Services enters its May 4 Q1 2026 earnings call having staged a remarkable comeback — up 21% over the past month to $297.59 — yet peers in the life sciences tools space spent last week in…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WST — free to start on ORTEX.
Sign up for free →Open WST on ORTEX